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 The  incidences  of  esophageal  adenocarcinoma  and   gastric
cardia  cancer  have  risen  steadily  in  the  United  States   (1 ) and
Europe  ( 2 ) over the last 3 decades; the incidence of cardia cancer
increased less than that of esophageal adenocarcinoma. By con-
trast, during the same period, the incidences of gastric noncardia
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countries   ( 3 )  .  Overall,  gastric  and  esophageal  cancers  are  the
 second  and  sixth  most  common  causes  of  cancer  death  in  the
world, respectively  ( 3 ) .
These similar incidence trends suggest that esophageal adeno-
carcinoma and gastric cardia cancer share, at least in part, some
etiologic factors despite their epidemiologic differences  ( 4 ) . Gas-
tric cardia cancer and esophageal adenocarcinoma are associated
with  gastroesophageal  reÀ ux  disease,  Barrett s  esophagus,  and
obesity  (5 ) . Infection with  Helicobacter pylori is an established
risk factor for gastric noncardia cancer but not for gastric cardia
cancer  ( 6 ), and  H. pylori infection has been asso ciated with a re-
duced risk of esophageal adenocarcinoma  (7 ) . To bacco smoking
is  causally  associated with  cardia  and  gastric  noncardia  cancer
( 8 ) and with both types (i.e., adenocarcinoma and squamous cell
carcinoma)  of  esophageal  cancer   ( 9 )  .  Dietary  factors  are  also
thought to have an important role in gastric and esophageal car-
cinogenesis,  but  evidence  from  cohort  studies  for  such  a  role,
particularly among Western populations, is lacking.
 Meat consumption is  a  dietary factor  that  has been linked to
several cancers. High meat consumption has been associated with
increased risks of colorectal cancer  (10 ), breast cancer  (11 ) and,
possibly, prostate cancer  (12 ) . However, a comprehensive review
on  nutrition  and  cancer  published  in  1997   ( 13 )  concluded  that
there  was  insuf¿ cient  evidence  that  total  meat  consumption  or
consumption of cured meat was related to the risk of gastric cancer
and that judgment about associations with the risk of esophageal
cancer was not possible because the evidence was limited. Since
then,  several  new cohort  studies  on  dietary factors  and  the  risk
of  gastric  cancer  have  contributed  to  the  available  evidence,
all  showing  either  no  association   ( 14 , 15 )  or  a  weak  but  non
statistically signi¿ cant association  (16 ) between total meat, beef,
or  pork  intake  and  the  risk  of  gastric  cancer.  Processed  meat
intake was statistically signi¿ cant and positively associated with
the risk of gastric cancer in two cohort studies  (15 , 17 ) but not in
three other studies  ( 14 , 18 , 19 ), and none of the studies took into ac -
count the anatomical site of the cancer (gastric cardia cancer versus
gastric  noncardia  cancer).  Associations  between  intakes  of  meat
and processed meat and the risk of esophageal cancer have not yet
been analyzed in a cohort study among a Western population.
 The goal  of  this study was to examine  associations between
meat  and  processed  meat  intake  and  the  risks  of  stomach  and
esophageal  adenocarcinomas  within  the  European  Prospective
Investigation Into Cancer and Nutrition (EPIC)  (20 ), a large pro-
spective cohort that includes participants with large differences in
meat consumption  (21 ) . Furthermore, we examined, for the ¿ rst
time, whether  H. pylori infection modi¿ es these associations by
conducting a nested case  control study within the EPIC cohort.
S UBJECTS AND M ETHODS
Study Subjects
 EPIC,  a  prospective  study  that  has  been  described  in  detail
elsewhere  (20 , 22 ), was designed to investigate the relationships
between dietary, lifestyle, genetic, and environmental factors and
the  incidence  of  cancer.  EPIC  cohorts  are  recruited  through
23 research centers located in 10 European countries: Denmark
(Aarhus, Copenhagen), France, Germany (Heidelberg, Potsdam),
Greece,  Italy  (Florence,  Turin,  Varese,  Naples,  Ragusa),  The
Netherlands  (Bilthoven,  Utrecht),  Norway,  Spain  (Granada,
Murcia,  Asturias,  Navarra,  San  Sebastian),  Sweden  (Malmo,
Ume ), and the United Kingdom (Norfolk,  Oxford).  The  EPIC
cohorts include a total of 521  457 subjects (368  010 women and
153  447 men), most of whom were recruited between 1992 and
1998 when they were 35  70 years old, usually from the general
population  residing  in  a  given  geographic  area,  town,  or  prov-
ince.   Exceptions  were the  French  cohort,  in  which participants
were recruited from among female members of the health insur-
ance agency for school employees; the Utrecht and Florence co-
horts, in which participants were recruited from among women
attending breast cancer screening programs; parts of the Italian
and Spanish cohorts,  in which participants were recruited from
among blood donors;  and most  of  the Oxford cohort,  in  which
participants  were  recruited  from  among  vegetarian  volunteers.
Blood samples (30 mL) were collected from approximately 74%
of  the  EPIC  participants.  After  extraction,  blood  samples  were
aliquoted into plastic straws of serum, plasma, white blood cells,
and erythrocytes and stored in liquid nitrogen (at   196 C) in a
central  repository.  Eligible  participants  gave  written  informed
consent and completed questionnaires on their diet, lifestyle, and
medical  history. Approval  for this study was obtained from the
ethical review boards of the International Agency for Research
on Cancer (IARC) and from all local participating centers.
 We  excluded  from  this  study  prevalent  cancer  cases  (138
 gastric  cancers  and  22  esophageal  adenocarcinomas)  and  2403
subjects who were lost to follow-up, as well as all subjects in the
Norway  cohort  because  of  the  small  number  of  incident  cases
(two gastric cancer cases from among 37  203 subjects at risk) and
the short follow-up.
 Diet  and  Lifestyle  Questionnaires
 The usual diet over the previous 12 months was measured at
EPIC study recruitment with the use of country-speci¿c validated
questionnaires  ( 20 , 23 ) . Most centers adopted a self-administered
dietary questionnaire that included 88  266 food items. In Greece,
Spain  , and Ragusa, the dietary questionnaire was administered at
a personal interview. Dietary questionnaires in France, Northern
Italy, Spain, The Netherlands, Germany, and Greece were quan-
titative,  estimating  individual  average  portion  size.  Those  in
Denmark, Naples, and Ume  were semiquantitative, with the same
standard portion size assigned to all participants. In Malm  and
the United Kingdom, diet  was measured by a dietary question-
naire combined with a food record. A separate lifestyle question-
naire  included questions  on  education level,  lifetime history of
smoking  and  alcohol  consumption,  occupation    , reproductive
 history,  use  of  hormones,  history  of  previous  illness  including
surgical operations, and physical activity level.
Follow-Up and Identi¿ cation  of  Cancer Cases
The follow-up was based on information in population cancer
registries, except in France, Germany Greece, and Naples, where
a  combination  of  methods  including  health  insurance  records,
cancer  and  pathology  hospital  registries,  and  active  follow-up
were used. Mortality data were collected from regional or na-
tio nal mortality registries. Follow-up began on the date of EPIC
recruitment  and  ended  on  the  date  of  diagnosis  of  gastric  or
esophageal cancer, the date of death, or date of the last complete
follow-up, whichever came ¿ rst. A total of 398 incident gastric
cancer cases and 188 incident esophageal cancer cases were re-
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December 31, 1999 or September 30, 2002, depending on the study
 center.  Cancer of the stomach included cancers coded as C16 ac-
cording to the 10th Revision of the International Statistical Classi¿ -
cation of  Diseases,  Injuries and Causes of Death  (24 ) . Validation
and con ¿ rmation of the diagnosis and classi¿ cation of tumor site
and of tumor morphology [according to International Classi¿ cation
of Diseases for Oncology, 2nd version, and Lauren classi¿ cation
of histologic type  (25 ) ] were carried out by a panel of patholo-
gists that included a representative from each country participat-
ing in EPIC and a coordinator (FC)  . The panel reviewed  material
provided  by  the  centers  (original  histology  slides  and/or  slices
obtained from paraf¿ n blocks of tumor specimens as well as the
original pathology reports). Among incident cancer cases, we ex-
cluded nonadenocarcinomas of the esophagus ( n = 121), gastric
lymphomas ( n = 26), gastric stump cancers ( n = 5), other nonad-
enocarcinoma gastric cancers ( n = 11), and otherwise  unspeci¿ ed
malignant neoplasms of the stomach ( n = 8). After these exclu-
sions, 348 gastric adenocarcinoma cases and 67 esophageal ade-
nocarcinoma cases were available for the analysis. Of these cases,
56% ( n = 195) were validated by a panel of pathologists through
review  of  the  available  histologic  material,  24%  (  n  =  83)  were
classi¿ ed according to the pathology report, and 20% ( n = 70) were
classi¿ ed on the basis of information reported by the cancer regis-
tries to the IARC central database. Gastric  cardia tumors included
gastroesophageal junction tumors ( n = 24).
Nested Case  Control Study of  + S\ORUL  Infection  Status
 We  conducted  a  nested  case   control  study  within  the  EPIC
cohort to examine whether the association between meat intake
and cancer risk was modi¿ ed by  H. pylori infection. Each case
subject with incident gastric cancer and an available blood sam-
ple was matched by sex, age group (  2.5 years), center, and date
of blood sample collection (  45 days) to four control  subjects
with available blood samples who were randomly selected from
among subjects in the cohort still at risk at the time of diagnosis
of each case.
 The concentration of anti- H. pylori immunoglobulin G (IgG)
antibodies  was measured by an  enzyme-linked immunosorbent
assay.  BrieÀ y,  dilutions  of  plasma  samples  (from  1  :  200  to
1 : 25  600) were incubated for 1 hour in 96-well À at-bottomed mi-
crotiter plates (Nunc, Roskilde, Denmark) coated with a whole-
cell lysate of  H. pylori [CCUG strain  ( 26 ) ] (1   g/mL). The wells
were  washed  extensively  and  incubated  for  3  hours  with  an
alkaline phosphatase-conjugated af¿ nity-puri¿ ed polyclonal goat
anti-human IgG (Sigma Chemical Co, St. Louis, MO). After fur-
ther  washings,  the  presence  of  bound  human  IgG  antibodies
speci¿  c  for   H.  pylori  was  detected  by  adding  1  mg/mL
p -nitrophenylphosphate (100   L/well) to the plates. Optical den-
sities were read after 1 hour at 405 and 650 nm.  H. pylori -speci¿ c
IgG  antibody  titers  were  expressed  as  arbitrary  enzyme-linked
immunosorbent assay units (EU) and were determined by inter-
polation relative to a standard curve constructed by serial  dilu-
tions of a standard positive control consisting of a pool of samples
from subjects known to be  infected with  H. pylori  and to  have
antibodies, as determined by Western blotting. A cutoff value of
100  EU  was  de¿ ned  using  serum  samples  from  individuals
negative for  H. pylori infection as determined by clinical, micro-
biologic, and serologic (western blotting) assays. Serum samples
giving EU values above 100 were considered positive for anti-
H. pylori IgG antibodies.
 Calibration  of  the  Dietary  Data
 We used a detailed computerized 24-hour diet recall (24HR)
method  (27 )  to  obtain  a  second dietary measurement  (between
1995 and  1999) from a random sample  of  the  cohort  (7.1% of
total cohort;  n = 36  994 participants) to calibrate dietary measure-
ments across countries and to correct for systematic over- or un-
derestimation of dietary intakes  ( 28 , 29 ) . Country- and sex-speci¿ c
calibration models were used to obtain individual predicted val-
ues of  dietary exposure for  all  participants.  Calibration  models
were  used  for  meat  intake  (total,  red,  processed,  and  poultry),
total vegetable intake, non-citrus fresh fruit intake, citrus intake,
and energy. The 24HR values were regressed on the intake values
for  meat  (total,  red,  processed,  and  poultry),  total  vegetables,
non-citrus  fresh  fruit,  and  fresh  citrus  fruit  and  the  values  for
energy obtained from the main dietary questionnaires. Consump-
tion values of zero in the main dietary questionnaires (reported
by 0% to 13% of the participants,  depending on the food vari-
able) were excluded from the regression calibration models; in-
stead, a zero was directly imputed as the corrected value. Weight,
height, age at study recruitment, and study center were included
as additional covariates, and data were weighted by the day of the
week and the season of the year in which the 24HR diet  recall
data were collected. Cox regression models were then run using
the predicted (calibrated) values of the meat variable of interest
and the calibrated values of the adjusting variables (total vegeta-
bles, non-citrus fresh fruit, citrus, and energy) for each individual
on a continuous scale, and the other adjusting variables used in
the noncalibrated model. The standard error of the deattenuated
coef¿ cient was calculated with bootstrap sampling in the calibra-
tion and disease models consecutively  (29 ) .
Statistical Methods
Analyses were conducted using Cox regression. We con¿ rmed
the proportional hazards assumption for meat  intake variables in
relation  to  gastric  and  esophageal  adenocarcinomas  using  the
likelihood ratio test, comparing models with and without product
terms  for  the  meat  variables  and  follow-up  time  (years).  Data
were strati¿ ed by study center and age at EPIC study recruitment
to control for differences in follow-up pro cedures and question-
naire design. Age at EPIC study recruitment was used as the time
scale variable in all models. Entry time was de¿ ned as age at re-
cruitment, and ¿ nal time was de¿ ned as the age at diagnosis for
case patients or the age at censoring for at-risk subjects. All mod-
els were adjusted for sex, height, weight, educational level, alco-
hol intake (grams/day) at baseline, smoking status (never, former,
or  current),  number  of  cigarettes  smoked  per  day  (in  current
smokers only), level of work-related physical activity (no activ-
ity,  sedentary,  standing,  manual,  or  heavy  manual),  level  of
 leisure-time  physical  activity  (as  continuous  metabolic  equiva-
lents for the energy expended-hour/week), energy intake (Kcal/
day), and consumption of total vegetables, non- citrus fresh fruit,
and citrus fruit (grams/day). Intakes of total meat, red meat, poul-
try, and processed meat were estimated, in grams per day, from
information  reported  in  the  dietary  questionnaires.  Red  meat,
poultry, and processed meat intakes were mutually adjusted for
in  the  models.  Red  meat  intake  included  pork,  beef,  veal,  and
lamb.  Poultry  intake  included  chicken,  turkey,  and  duck.  Pro-
cessed  meat  intake  included  ham,  bacon,  sausages,   processed
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( 21 )  .  Intakes were analyzed as continuous variables (per  100-g
increase for total meat intake, per 50-g increase for red and pro-
cessed meat intakes, and per 10-g increase for poultry intake) and
as  categorical  variables  using  EPIC  study-wide  sex-speci¿ c
quartiles  for  analyses  of  associations  with  gastric  cancer  risk
and tertiles for analyses of associations with esophageal adenocar-
cinoma  risk.  To  calculate   P  values  for  trends  across   quartiles
(or tertiles), participants were assigned a score ranging from 1 to 4
(or 1 to 3) according to their quartile (or  tertile) of  intake and this
variable was entered as a continuous term in the Cox regression
models. Separate analyses were done for men and women, but be-
cause no  substantial  differences by sex  emerged, we present  the
results for both sexes combined in this report.  Subsequent analyses
were  performed after  exclusion of  case  patients  who were  diag-
nosed during the ¿ rst 2 years of follow-up. The Wald statistic  ( 30 )
was used to test for homogeneity of risk for cardia and gastric non-
cardia tumors.
 The  odds  ratio  (OR)  for  association  of  meat  and  processed
meat intake in  H. pylori antibody-positive and -negative subjects
in  the  nested  case   control  study  was  estimated  by  multiple
 unconditional  logistic  regression,  including  matching  variables
in the model. The statistical signi¿ cance of interactions between
intakes of different meat variables and  H. pylori infection were
 assessed  using  a  likelihood  ratio  test.  All  statistical  tests  were
two-sided, and  P values less than .05 were considered statisti cally
signi¿ cant.
R ESULTS
 During a mean follow-up of 6.5 years (3  110  034 person-years)
starting  in  1991,  348  eligible  stomach  adenocarcinomas  and  67
esophageal adenocarcinomas were diagnosed ( Table 1 ). The
stomach adenocarcinomas included 101 cancers in the gastric car-
dia (24 of which were in the gastroesophageal junction), 166 can-
cers  in  the  distal  part  of  the  stomach,  and  81  cancers  (23%) of
unknown location.  According  to  Lauren  classi¿ cation  ( 25 ) ,  116
gastric cancers (33.3%) were  intestinal, 120 (34.5%) were diffuse,
four  (1.1%)  were  mixed,  and  108  (31.0%)  were  unclassi¿ ed or
unknown. We excluded from the analyses individuals who were
in the top or bottom 1% of energy intake  ( 31 ) (seven subjects with
gastric cancer, one subject with esophageal adenocarcinoma, and
9426 members of the cohort) and individuals with missing dietary
information  (11  subjects  with  gastric  cancer,  one  subject  with
esophageal  adenocarcinoma,  and  6486  members  of  the  cohort).
The ¿ nal sample for analyses included 330 gastric cancer patients
(56%  of  whom  were  men)  and  65  esophagus   adenocarcinoma
patients (77% of whom were men). A total of 241 gastric cancer
patients with available blood samples and 1141 matched control
subjects were included in the nested case  control study.  Table 1
also  shows  the  mean  intakes  of  red  meat,  processed  meat,  and
poultry  by  country,  which  were  estimated  using  the  24HR data
collected  in  the  calibration  study.   Processed  meat  consumption
varied between countries by approximately 10-fold, and red meat
consumption varied by two- to threefold.
 Baseline characteristics of the participants according to meat
intake  levels  are reported in   Table 2  .  Subjects with the highest
intake  of  red meat were more  likely to have  ever  smoked than
subjects  with  the  lowest  intake  of  red  meat,  and  subjects  with
the highest intake of processed meat had lower intakes of citrus
and non-citrus fruits and vegetables than subjects with the lowest
intake of processed meat.  Table 3 shows the mean intake levels
of red meat, processed meat, and poultry within each study-wide
quartile of intake. For both men and women, the mean intake of
red  meat  in  the  highest  intake  quartile  was  more  than  twofold
higher than that in the lowest intake quartile. For men, the mean
intake  of processed meat in the highest  intake quartile  was 4.5
times  higher  than  that  in  the  lowest  intake  quartile,  and  for
women, it was 3.5 times higher.
Table 4  shows the hazard ratios (HRs) for risks of gastric can-
cer  and  esophageal  adenocarcinoma associated  with total  meat
intake. In the observed uncalibrated analysis, there was a statisti-
cally  signi¿ cant  positive  association  between total  meat  intake
and the risk of gastric cancer ( P trend = .01). The calibrated hazard
ratio for a 100-g/day increase in intake was 2.03 (95% CI = 1.28
to 3.22). The positive association between total meat intake and
the risk of gastric cancer was restricted to gastric noncardia can-
cers  (calibrated  HR for  a  100-g/day  increase  in  intake  =  3.52;
95% CI = 1.96 to 6.34); there was no association between total
meat intake and the risk of cardia cancer ( P for heterogeneity = .01).
No differences between the hazard ratios of intestinal and diffuse
types for total meat intakes were observed. We also observed a
non  statistically signi¿ cant  positive  association  between  total
meat intake and the risk of esophageal  adenocarcinoma for the
whole cohort (calibrated HR for a 100-g/day increase in intake =
1.84;  95%  CI  =  0.78  to  4.39).  In  the  uncalibrated  model,  we
observed  a  positive  association  of  borderline  statistical  signi¿ -
cance  between  red  meat  intake  and  gastric  cancer  risk  for  the
highest level of consumption ( P trend = .05); the calibrated hazard
ratio  was  not  statistically  signi¿ cant. This positive association
between  red  meat  intake  and  gastric  cancer  risk  was  restricted
to  noncardia  tumors  (calibrated  HR  for  a  50-g/day  increase  in
intake = 1.73; 95% CI = 1.03 to 2.88;  P for heterogeneity = .19).
A non  statistically signi¿ cant  positive  association  between red
meat intake and esophageal adenocarcinoma was observed in the
uncalibrated model, but not in the calibrated model.
 We  observed  a  statistically  signi¿ cant  positive  association
 between poultry consumption and the risk of gastric cancer for
the highest category of intake in the uncalibrated analysis ( Table
4 ). However, this association disappeared in the calibrated model.
We  also  observed  a  statistically  signi¿ cant  positive  association
between  poultry  intake  and  esophageal  adenocarcinoma  (cali-
brated HR for a 10-g/day increase in intake = 1.14; 95% CI = 1.00
to 1.30). We found a statistically signi¿ cant positive association
between processed meat intake and gastric cancer risk ( P trend =
.02), with a 62% increase in risk for the highest versus the lowest
quartile of intake. This association between processed meat and
the risk of gastric cancer was observed only for noncardia tumors
(calibrated  HR  for  a  50-g/day  increase  in  intake  =  2.45;  95%
CI  =  1.43  to  4.21;   P  for  heterogeneity  =  .02).  Processed  meat
intake was also positively associated with the risk of  esophageal
ade nocarcinoma (HR for the highest versus the  lowest tertile of
 intake  =  3.54;  95%  CI  =  1.57  to  7.99;   P trend  =  .002),  but  the
 association  was  not  statistically  signi¿ cant  in  the  calibrated
model. In this study population, the absolute risk of development
of  gastric  adenocarcinoma  within  10  years  for  a  study  subject
aged  60  years  was  0.26%  for  the  lowest  quartile  of  total  meat
intake and 0.33% for the highest quartile of total meat intake.
To eliminate the potential effects of early undiagnosed gastric
or esophageal cancers, we repeated our analyses after excluding
case  patients  whose  cancers  were  diagnosed  during  the  2  ¿ rst
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modi¿ ed their  diet  during the early, prediagnostic phase of the
disease. None of our ¿ ndings for associations between red meat,
processed meat, or poultry and the risk of either gastric cancer or
esophageal  adenocarcinoma  changed  after  we  excluded  these
case patients. In addition, although the number of cancer cases was
small,  after  stratifying  the  sample  by  Northern  versus  Southern
European countries (data not shown) the results were very  similar .
We also examined associations with different subgroups of red
and processed meat, but we did not ¿ nd that a particular type of
either red meat or processed meat was more strongly associated
with gastric cancer than other types. Intakes of red and processed
meat  were  highly  correlated  (Pearson s   r  =  .65),  whereas  the
 correlation  between intakes of processed meat and poultry was
very low (Pearson s  r = .05), and the correlation between intakes
of red meat and poultry was moderate (Pearson s  r = .23).
Finally, we conducted a nested case  control study to examine
whether  H. pylori infection (as assessed by plasma level of anti-
bodies against  H. pylori ) modi¿ ed the associations between total
meat, red meat, poultry, or processed meat intakes and the risk of
gastric cancer ( Table 5 ).  We observed a statistically  signi¿ cant
Table 4.  Multivariable hazard ratio (HR) of stomach and esophageal adenocarcinoma (95% con¿ dence intervals) for observed and calibrated intakes of total meat,
red meat, poultry, and processed meat according to anatomic location and histologic type of gastric cancer in the European Prospective Investigation Into Cancer
and Nutrition (EPIC) cohort*
Cancer site/type
and type of meat
Observed quartiles/tertiles   Continuous
No. of cases 2 3 4  P trend Observed Calibrated
Stomach 330
Total meat 1.05 (0.75 to 1.49) 1.59 (1.12 to 2.24) 1.50 (1.01 to 2.23) .01 1.30 (1.05 to 1.62) 2.03 (1.28 to 3.22)
Red meat 1.22 (0.87 to 1.71) 1.27 (0.89 to 1.82) 1.50 (1.02 to 2.22) .05 1.14 (0.97 to 1.33) 1.31 (0.89 to 1.94)
Poultry 1.29 (0.93 to 1.80) 1.30 (0.92 to 1.83) 1.47 (1.04 to 2.10) .04 1.01 (0.96 to 1.07) 0.95 (0.81 to 1.13)
Processed meat 1.10 (0.76 to 1.58) 1.16 (0.79 to 1.69) 1.62 (1.08 to 2.41) .02 1.18 (0.97 to 1.43) 1.64 (1.07 to 2.51)
Cardia 94
Total meat 0.82 (0.43 to 1.57) 1.15 (0.60 to 2.19) 1.00 (0.48 to 2.08) .75 0.95 (0.63 to 1.43) 0.84 (0.31 to 2.28)
Red meat 1.56 (0.80 to 3.02) 1.48 (0.73 to 3.02) 1.17 (0.53 to 2.60) .85 1.04 (0.79 to 1.38) 1.09 (0.46 to 2.59)
Poultry 1.37 (0.72 to 2.61) 1.67 (0.88 to 3.19) 1.57 (0.80 to 3.09) .16 0.96 (0.86 to 1.08) 0.82 (0.60 to 1.14)
Processed meat 1.19 (0.61 to 2.34) 1.04 (0.51 to 2.12) 1.14 (0.52 to 2.49) .91 0.89 (0.59 to 1.34) 0.76 (0.29 to 1.96)
Noncardia 159
Total meat 1.49 (0.89 to 2.48) 1.95 (1.15 to 3.30) 2.19 (1.22 to 3.93) .01 1.67 (1.25 to 2.24) 3.52 (1.96 to 6.34)
Red meat 0.90 (0.56 to 1.44) 1.29 (0.79 to 2.10) 1.65 (0.97 to 2.82) .03 1.30 (1.04 to 1.63) 1.73 (1.03 to 2.88)
Poultry 1.17 (0.71 to 1.94) 1.51 (0.92 to 2.46) 1.65 (1.00 to 2.74) .03 1.03 (0.96 to 1.11) 1.01 (0.81 to 1.27)
Processed meat 1.02 (0.60 to 1.71) 1.02 (0.59 to 1.77) 1.92 (1.11 to 3.33) .01 1.36 (1.06 to 1.74) 2.45 (1.43 to 4.21)
Intestinal 109
Total meat 1.05 (0.59 to 1.87) 1.49 (0.82 to 2.70) 1.24 (0.61 to 2.51) .33 1.31 (0.90 to 1.92) 2.14 (0.87 to 5.23)
Red meat 1.29 (0.73 to 2.30) 1.52 (0.83 to 2.78) 1.23 (0.61 to 2.51) .46 1.03 (0.76 to 1.40) 1.10 (0.50 to 2.44)
Poultry 1.02 (0.57 to 1.80) 1.06 (0.58 to 1.93) 1.46 (0.81 to 2.62) .21 1.03 (0.93 to 1.13) 0.94 (0.70 to 1.27)
Processed meat 1.62 (0.84 to 3.11) 1.67 (0.84 to 3.33) 1.78 (0.84 to 3.77) .18 1.27 (0.93 to 1.75) 2.11 (1.08 to 4.14)
Diffuse 116
Total meat 0.80 (0.44 to 1.46) 1.76 (1.00 to 3.07) 1.34 (0.69 to 2.58) .09 1.23 (0.85 to 1.80) 1.52 (0.67 to 3.43)
Red meat 1.11 (0.65 to 1.91) 0.95 (0.51 to 1.75) 1.74 (0.93 to 3.24) .13 1.13 (0.84 to 1.51) 1.10 (0.54 to 2.23)
Poultry 1.33 (0.76 to 2.34) 1.50 (0.84 to 2.67) 1.87 (1.05 to 3.33) .03 1.05 (0.97 to 1.14) 1.04 (0.78 to 1.39)
Processed meat 0.75 (0.39 to 1.45) 0.88 (0.45 to 1.70) 1.47 (0.76 to 2.82) .10 1.04 (0.75 to 1.43) 1.40 (0.69 to 2.85)
Esophagus 65
Total meat 0.96 (0.48 to 1.93) 1.79 (0.86 to 3.75) N/A .10 1.56 (1.11 to 2.19) 1.84 (0.78 to 4.39)
Red meat 1.73 (0.86 to 3.48) 1.67 (0.75 to 3.72) .23 1.13 (0.84 to 1.51) 0.75 (0.26 to 2.13)
Poultry 1.29 (0.67 to 2.49) 1.93 (0.99 to 3.76) .05 1.12 (1.06 to 1.20) 1.14 (1.00 to 1.30)
Processed meat 2.08 (0.96 to 4.47) 3.54 (1.57 to 7.99)  .002 1.16 (0.82 to 1.65) 1.44 (0.64 to 3.22)
* Reference categories are the lowest quartile and tertile for quartile and tertile analyses, respectively. For continuous analysis, HRs are for a daily intake increase of
100 g (total meat), 50 g (red and processed meat), or 10 g (poultry). The full-cohort analysis was strati¿ ed by center and age at EPIC study entry and adjusted by sex,
height, weight, education level, tobacco smoking, cigarette smoking intensity, work and leisure physical activity, alcohol intake, energy intake, vegetable intake, citrus
fruit intake, and non-citrus fruit intake. Red meat, poultry, and processed meat intakes were mutually adjusted. N/A = not applicable.
 For esophageal cancer, tertiles were used instead of quartiles because of the small sample size. The cutoff points for the total meat tertiles, in grams/day, were
(men/women): 92.64/64.56 and 148.88/107.96. The cutoff points for the red meat tertiles, in grams/day, were (men/women): 34.15/22.98 and 72.61/51.18. The cutoff
points for the poultry tertiles, in grams/day, were (men/women): 9.13/7.50 and 21.98/20.35. The cutoff points for the processed meat tertiles, in grams/day, were (men/
women): 21.58/12.60 and 49.15/30.48. Quartiles and tertiles are full-cohort sex speci¿ c.
Table 3.  Mean intake (range) of total meat, red meat, poultry, and processed meat according to sex-speci¿ c study-wide quartiles in the European Prospective
Investigation Into Cancer and Nutrition (EPIC) cohort *
Men  Women
Type of meat Quartile 1 Quartile 2 Quartile 3 Quartile 4 Quartile 1 Quartile 2 Quartile 3 Quartile 4
Total meat 91.0 (0  78) 127.4 (78  119) 152.3 (119  166) 186.7 (166  1196) 60.5 (0  53) 79.7 (53  86) 94.0 (86  121) 117.9 (121  929)
Red meat 34.3 (0  26) 51.5 (26  52) 66.5 (52  84) 84.6 (84  1087) 22.6 (0  17) 31.2 (17  36) 40.6 (36  61) 52.9 (61  584)
Poultry 10.2 (0  7) 15.5 (7  16) 21.9 (16  29) 34.0 (29  690) 11.6 (0  5) 13.4 (5  14) 18.7 (14  26) 27.2 (26  690)
Processed meat 19.1 (0  16) 46.9 (16  34) 64.8 (34  59) 85.6 (59  731) 13.1 (0  9) 25.8 (9  20) 34.4 (20  37) 45.4 (37  771)
* Mean intake reported as g/day. Ranges are based on values reported on the food questionnaires, and the means were estimated from the 24-hour dietary recall data
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Table 5.  Nested case  control study of the risk of stomach adenocarcinoma by calibrated intakes of total meat, red meat, poultry, and processed meat according
to anatomic location among  Helicobacter pylori antibody-positive and -negative subjects in the European Prospective Investigation Into Cancer and Nutrition
(EPIC) cohort *




Case patients with stomach
adenocarcinoma
Case patients with gastric
cardia adenocarcinoma
Case patients with gastric
noncardia adenocarcinoma
Type of meat No. OR (95% CI)  P  No. OR (95% CI)  P  No. OR (95% CI)  P 
Total meat Negative 372 40 1.60 (0.26 to 9.96) .76 22 3.03 (0.26 to 35.1) .43 12 0.21 (0.001 to 38.0) .14
Positive 769 201 2.57 (1.25 to 5.25) 47 0.52 (0.12 to 2.32) 113 5.32 (2.10 to 13.4)
Red meat Negative 372 40 1.78 (0.27 to 11.7) .54 22 1.55 (0.10 to 24.5) .20 12 1.22 (0.01 to 237) .28
Positive 769 201 1.26 (0.69 to 2.32) 47 0.56 (0.16 to 2.00) 113 1.93 (0.90 to 4.12)
Poultry Negative 372 40 1.05 (0.56 to 1.98) .71 22 1.22 (0.55 to 2.70) .14 12 1.76 (0.34 to 9.19) .79
Positive 769 201 1.07 (0.84 to 1.36) 47 0.75 (0.46 to 1.22) 113 1.13 (0.80 to 1.60)
Processed meat Negative 372 40 0.45 (0.05 to 4.01) .48 22 0.86 (0.03 to 27.0) .42 12 0.002 (<0.001 to 62.6) .25
Positive 769 201 2.00 (1.06 to 3.79)  47 1.62 (0.47 to 5.55)  113 2.67 (1.20 to 5.93)
* Odds ratios (ORs) are for a daily intake increase of 100 g (total meat), 50 g (red and processed meat), or 10 g (poultry). Adjusted by sex, age at EPIC study en-
try, study center, date of blood extraction, height, weight, education level, tobacco smoking, cigarette smoking intensity, work and leisure physical activity, alcohol
intake, energy intake, vegetable intake, and citrus and non-citrus fruit intake. Red meat, poultry, and processed meat intakes were mutually adjusted. CI = con¿ dence
interval.
 From two-sided likelihood ratio test for interaction with  H. pylori infection status.
positive association between total meat intake (OR for a 100-g/
day increase in intake = 5.32; 95% CI = 2.10 to 13.4) and pro-
cessed meat intake (OR for a 50-g/day increase in intake = 2.67;
95% CI = 1.20 to 5.93)  and risk of gastric noncardia cancer   in
H.  pylori  antibody-positive  subjects.  There  was  no  association
between total  and  processed meat  intake  and  gastric  noncardia
tumors  in   H.  pylori  antibody-negative  subjects;  however,  the
95% con¿ dence intervals were wide and the number of  H. pylori
antibody-negative case patients was low. Poultry intake was not
associated  with  gastric  noncardia  cancer  risk  in   H.  pylori
antibody-positive subjects. Tests for interaction were not statisti-
cally signi¿ cant.
D ISCUSSION
 This  is  the  largest  cohort  study  to  examine  associations  be-
tween intakes of fresh and processed meats and the incidence of
cardia  and  gastric  noncardia  cancer  in  Western  countries  and
the ¿ rst study to examine intakes of these foods and risk of eso ph-
ageal adenocarcinoma. This is also the ¿ rst cohort study, to our
knowledge, to explore modi¿ cation of the effects of meat intake
by  H. pylori  infection status.  We observed positive and statisti-
cally  signi¿ cant  associations  between  intakes  of  total,  red,  and
processed meat  and  the  risk  of  gastric  noncardia cancer.  All  of
these associations seemed to be restricted to the  H. pylori -infected
subjects. Furthermore, there was no association between poultry
intake and the risk of gastric noncardia cancer. Cardia gastric can-
cer was not associated with meat intake of any type. We observed
non  statistically signi¿ cant  positive  associations  between  the
risk of esophageal adenocarcinoma and intakes of total meat and
processed meat and a potential association with poultry intake. In
this study population, the absolute risk of development of gastric
adenocarcinoma within 10 years for a study subject aged 60 years
was 0.26% for the lowest quartile of total meat intake and 0.33%
for the highest quartile of total meat intake.
The ¿ nding that  H. pylori  infection modi¿ es the associations
between total and processed meat intakes and the risk of gastric
noncardia cancer may explain the different effect of meat intake
between  cardia  and  noncardia  tumors.  A meta-analysis  of  pro-
spective studies found that cardia tumors are not associated with
H. pylori infection  (6 ) . The mechanisms involved in the relation-
ships among meat intake,  H. pylori infection, and gastric cancer
risk  have  yet  to  be  fully  elucidated.  Red  meat  is  an  important
source of iron, and it has been suggested that iron is an essential
growth factor for  H. pylori ( 32 ) . However, other, unknown factors
must play a role in the cancer risk because, although the intake of
red meat has increased in most European countries during the last
decades, the prevalence of  H. pylori infection and the incidence of
gastric noncardia cancer has decreased over the same period  (3 ) .
 Few cohort studies have explored associations between meat
and processed meat intakes and the risk of gastric cancer. With
respect to fresh meat intake and gastric cancer risk, three cohort
studies  ( 14 , 15 , 33 ) observed no associations with total meat, beef,
or pork intakes, whereas one study  (16 ) found a weak but non
statistically signi¿ cant  association.  Processed  meat  (such  as
 bacon  or  sausage)  was  statistically  signi¿ cantly  and  positively
associated with gastric cancer in two cohort studies  (15 , 17 ) but
not  in  three  other  studies   ( 14 , 18 , 19 )  .  However,  none  of  these
studies  distinguished  between  cardia  and  noncardia  tumors.
 Results  from  case   control  studies  have  also  been  inconsistent
( 13 )  .  Some  studies   ( 34 , 35 )  observed  a  statistically  signi¿ cant
positive association between red meat intake and gastric cancer
risk,  whereas  other  studies   (36  38 )  found  a  positive  but  non
statistically signi¿ cant  association.  However,  the  two  largest
studies  ( 39 , 40 ) found no association between red meat intake and
gastric cancer risk. With respect to esophageal cancer, the effect
of meat and processed meat intake has never been analyzed in a
cohort  study  for  a  Western  population,  and  the  evidence  from
case  control studies is limited and inconsistent  (13 ) .
Several plausible mechanisms have been suggested to explain
the possible causal relationship between meat intake and cancer
risk   ( 41 )  .  These  mechanisms  involve  potential  effects  of  high
levels of heme (a red organic pigment containing ferrous iron) in
red meats, of fat and protein, of nitrite and nitrosamines, and of
salt,  as  well  as of heterocyclic  amines and polycyclic  aromatic
hydrocarbons. One study  ( 41 ) showed that red meat intake had a
consistent  dose  response  on  the  endogenous  formation  of
n - nitroso compounds measured in fecal samples, whereas white
meat intake had no effect. This effect seems to be associated with
the  content  of  heme,  rather  than with  the content  of  protein or
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 consists  mainly  of  pork  and  beef  products  and  is  an important
source of salt, nitrites, and exogenous nitrosamines in the human
diet  ( 43 ) . Nitrosamines have been shown to cause a wide range of
tumors in more than 40 animal species and may be speci¿ cally
involved in the etiology of gastric cancer and esophageal cancer
( 44 ),  although  so  far,  there  is  no  conclusive  epidemiologic
 evidence that these compounds are related to cancer risk in hu-
mans.  Although  the  levels  of  sodium  nitrite  in  foods  have  de-
creased during the last 20 years  (43 ), it is still widely used as a
food preservative in cured meat. Nitrites and nitrates can nitro-
sate  amines  and  amides,  thus  forming  potentially  carcinogenic
N  -nitroso  compounds   ( 45 )  .  Nitrosating  agents   ( 46 )  are  over-
produced under chronic inÀ ammatory conditions, a common step
in the gastric precancerous process. In addition, salt is thought to
induce an inÀ ammatory process that leads to damage of the pro-
tective  stomach  mucosa   (13 ). H. pylori  infection  may  interact
with salt, enhancing carcinogenesis after the gastric epithelium is
damaged  ( 13 ) . It has also been suggested that the effect of salt  on
stomach  inÀ ammation  could  be  stronger  if  nitrosamine  com-
pounds are involved   ( 13 ).
 Any effect of meat on cancer risk could be associated also
with  the  content  of  heterocyclic  amines  and  polycyclic  aro-
matic hydrocarbons. Heterocyclic amines  (47 ) and polycyclic
aromatic hydrocarbons  (48 ) are formed by cooking meat at a
high temperature or over an open À ame. We could not assess
the  asso  ciations  of  these  chemicals  with  the  risks  of  gastric
cancer and esophageal adenocarcinoma because only some of
the EPIC  dietary questionnaires recorded detailed information
about the method used to cook meat or the frequency of intake
of more-well-done versus less-well-done meat or of browned
meats. However, on the basis of the information obtained from
the 24HR dietary recall, we know that the frequency of use of
high-temperature  cooking  methods  (i.e.,  grilling,  frying,  or
barbecuing)  varied  from 15%  in  the  EPIC  cohort  of  Italy  to
49% in  the EPIC cohort  of  The  Netherlands  (49 ) . Regarding
our ¿ nding  of  a  possible  association  between  poultry  intake
and the risk of eso p hageal adenocarcinoma, we are not able to
¿ nd an explanation. White meat (i.e., poultry) is not a source
of  the  endogenous  formation  of   N  -nitroso  compounds   ( 41 ),
and the frequency  of  use of  high-temperature cooking  meth-
ods  for  chicken  in  most  of  the  EPIC  countries  was  lower
than 30%, although it varied from 8.3% in France to 88.3% in
Germany  ( 49 ) .
 Our study has several potential limitations. First, we did not
collect information about family history of gastric cancer. How-
ever, a Japanese study  (50 ) that was designed to assess the inÀ u-
ence  of  this  information  observed  no  differences  in  lifestyle
and  risk  factor  patterns  between  gastric  cancer  patients  with
and without a family history of this disease. Second, our results
could also be affected by measurement error in dietary intake, a
common limitation of epidemiologic studies. The wide range of
intakes of meat and processed meat reported in the EPIC study
reduced, but did not eliminate, potential effects of measurement
error.  Because the magnitude of  the  distortion  in the  estimated
relative risk depends on the ratio of the inter-individual variation
to the intra-individual  measurement error   (51 )  ,  regression dilu-
tion should have been lessened by the inclusion of a diverse range
of  intakes.  In  addition,  our  results  for  the  association  between
meat intake and cancer risk were calibrated against  a more de-
tailed  method  of  dietary  assessment  (the  24HR dietary  recall).
We have emphasized the results that were consistent in the origi-
nal  categorical  and  the  continuous  calibrated  models  and  note
that the study is based mostly in con¿ rmed adenocarcinoma cases
validated by a panel of pathologists.
 In  conclusion,  despite  the  relatively  low  number of  cardia
and  gastric  noncardia  cancer  and  esophageal  adenocarcinoma
cases  in  our  study  and  the  need  for  more  cases  and  years  of
follow-up, our results suggest that meat intake is associated with
the risk of gastric noncardia cancer and adenocarcinoma of the
esophagus.  We  observed  a  statistically  signi¿ cant  increase  in
gastric noncardia cancer risk associated with the intake of total,
red,  and  processed  meat.  The  associations  with  total  and  pro-
cessed  meat  seemed  to  be  restricted  to   H.  pylori antibody-
 positive  subjects.  Cardia  cancer  was  not  associated  with  any
type of meat intake. Given the low 5-year relative survival rates
of  European  patients  with gastric  cancer  or  esophageal  cancer
(23%  and  10%,  respectively)   ( 52 ) , identi¿ cation  and  better
 control  of  risk  factors  represent  the  most  effective  ways  for
 reducing the burden of these tumors.
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